26 April 2018 First-quarter 2018 success story continues Webcast for investors, analysts & media Basel, 26 April 2018 Disclaimer This presentation contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Straumann Group to differ materially from those expressed or implied in this presentation. The Group is providing the information in this presentation as of this date and does not undertake any obligation to update any statements contained in it as a result of new information, future events or otherwise. The availability and indications/claims of the products illustrated and mentioned in this presentation may vary according to country. 2 1
First quarter highlights Marco Gadola, CEO Strong start to 2018 REVENUE GROWTH REGIONS CHF 324m +15% organic 1 Highest growth in Strong organic growth across all regions and businesses. +22% in CHF Acquisition effect: 5% points FX effect: 2% points APAC KEY DRIVERS TECHNOLOGY OUTLOOK 2 EMEA & NAM each contribute 30% of overall growth. LATAM posts best quarter in 4 years. Total solutions Dental Monitoring Continued growth Premium business driven by Straumann BLT. Dynamic growth in non-premium driven by Neodent and Medentika. Investment DM secures access to artificial intelligence for dental applications. Low double-digit organic growth expected in 2018, with further EBITDA margin improvement. 4 1 Organic growth i.e. excluding the effects of currency fluctuations and acquired/divested business activities 2 Barring unforeseen events/circumstances 2
Good momentum maintained NAM Q1 2018 17.2% FY 2017 18.7% EMEA Q1 2018 9.8% FY 2017 11.3% APAC Q1 2018 25.0% FY 2017 23.6% 5 LATAM Q1 2018 21.5% FY 2017 14.6% Group Q1 2018 15.3% FY 2017 15.7% Business and regional review Peter Hackel, CFO 3
Strong performance all round Revenue development (CHFm, rounded) 21.7% in CHF 266.3 3.3 11.5 281.1 13.1 13.2 15.3% organic 11.8 Change in organic growth 5.0 324.1 Regional share of organic growth 11% LATAM 27% 31% APAC North America 9.8% 17.2% 25.0% 21.5% 31% EMEA Revenues Q1 2017 FX effect M&A effect Revenues Q1 2017 @ FX 2018 EMEA North America APAC LATAM Revenues Q1 2018 7 EMEA & North America growth heavyweights EMEA 45% of Group 8.0% Revenue change (organic) 56% 15.0% 10.1% 9.9% 9.9% 9.8% Robust growth in EMEA despite Easter holiday timing Strong performances in Iran, Russia, Saudi Arabia, Turkey & UK Batigroup (Turkey) & Dental Wings consolidated North America 28% of Group Q4 16.0% Q1 2017 17.2% Q2 17.2% Q3 17.0% Q4 Q1 2018 22.7% 17.2% Double-digit growth in Canada & US BLT drives premium business; Medentika adds to non-premium expansion Digital business expands Q4 Q1 2017 Q2 Q3 Q4 Q1 2018 8 4
Strong Asia Pacific solid pace in Latin America Asia/Pacific 18% of Group Revenue change (organic) 25.7% 20.5% 19.4% 27.9% 56% 22.1% 25.0% Strong growth in all subsidiaries Dynamic performance in China reflects sales-force expansion and increased T&E activities Australia enters non-premium segment with Neodent Latin America 9% of Group Q4 Q1 2017 Q2 15.0% 15.3% 12.8% Q3 18.9% Q4 Q1 2018 21.5% 11.6% Strong growth in Brazil driven by: salesforce & store-network expansion, excellent CIOSP event, entry into biomaterials, Neodent GM, launch of BLT SmallOne Dynamic growth in Columbia & Mexico; strong results in Argentina & Chile Q4 Q1 2017 Q2 Q3 Q4 Q1 2018 9 Q1 growth led by implants & restorative strong demand for digital products Implants Restorative & Digital Biomaterials 10 5
Strategy in action moving forward Marco Gadola, CEO Investment in artificial intelligence Capital injection in return for a minor stake in Dental Monitoring (DM) and global distribution rights The world s first dental monitoring solution using smart phones and artificial intelligence technology to increase treatment efficiency Companies to develop further applications, e.g. to monitor implants and to analyze intra-oral scans 12 6
Enhanced chairside digital solutions TRIOS3 intraoral scanner launched in US TRIOS Design Studio software enters limited market release, offering seamless chairside workflow to Trios users 13 CARES CADCAM service launched in China State-of-the art milling center inaugurated in Shenzhen Initially to serve the domestic market for tooth-borne prosthetics CADCAM global milling capabilities Arlington USA Curitiba Brazil Markkleeberg Germany Shenzhen China Narita Japan 14 7
Converging premium & non-premium activities to unlock selling opportunities Straumann & Instradent activities converged in 15 countries New set-up facilitates non-premium roll-out; Neodent launched in Australia, France, Germany, and Nordics Existing organizations able to market more products and make resources available for non-premium brands Single eshop for all brands; customers have one account and can order everything together with one invoice 15 Bringing Neodent s innovative Grand Morse system to customers around the world Complete new system for all clinical needs; fully-tapered design, comprehensive and easy-to-use prosthetics Very well received in Brazil; full market release underway in Benelux, Chile, France, Germany, Hungary, Iberia, Iran, Italy, Nordics, South Africa, UK Launches to follow in North America, APAC and LATAM in mid-year 16 1 Data on file 8
Ortho business progressing well since acquisition Customer base expands 10%; steep rise in specialists Q1: significant case growth; proportion of cases from international markets reaches 15% NAM sales teams leveraged; coverage increased Pilot programs: Europe very positive, further countries added; mini-pilot in Japan Building to full market releases in Europe, LATAM & APAC in 2019 +51% case starts Q1 2017 Q2 Q3 Q4 Q1 2018 Combined treatment pilot started in Spain 17 Outlook 2018 9
Our 2018 guidance remains unchanged Barring unforeseen circumstances Market growth Global implant market to grow at approx. 4% Our revenue growth Confident to outperform and achieve organic revenue growth in the low double-digit range Profitability Further improvement in EBITDA margin; EBIT margin stable 19 Questions & answers & 10
26 April 2018 Calendar of upcoming events 2018 Event Location 26 April Q1 revenue Webcast 07 May Milano / Lugano 23 May Zurich 29 May Boston 30 May Stifel Dental & Veterinary conference New York 31 May New York 05/06 June Vontobel summer conference Interlaken (CH) 19 June Frankfurt 20 June Netherlands 14 August H1 results publication Basel HQ Social media Type Source Analyst Talk (Shift + left mouse) Executive interviewed by analysts straumann.com (Investors) / youtube.com StraumannIR (Shift + left mouse) Investor Relations Twitter @StraumannIR 21 Thank you Thank you investor.relations@straumann.com 11